Nurix Therapeutics (NRIX) Reports First Clinical Evidence of CNS Activity of NX-5948
Go back to Nurix Therapeutics (NRIX) Reports First Clinical Evidence of CNS Activity of NX-5948| (NASDAQ: NRIX) | Delayed: 18.95 +0.30 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.65 | 52 Week High | $ | |||
| Open | $18.49 | 52 Week Low | $ | |||
| Day High | $19.08 | P/E | N/A | |||
| Day Low | $18.39 | EPS | $ | |||
| Volume | 294,016 | |||||

